BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33257106)

  • 1. Preoperative predictive criteria for mastoid extension in pars flaccida cholesteatoma in assessments using temporal bone high-resolution computed tomography.
    Baba A; Kurihara S; Ogihara A; Matsushima S; Yamauchi H; Ikeda K; Kurokawa R; Ota Y; Takahashi M; Sakurai Y; Motegi M; Komori M; Yamamoto K; Yamamoto Y; Kojima H; Ojiri H
    Auris Nasus Larynx; 2021 Aug; 48(4):609-614. PubMed ID: 33257106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attic cholesteatoma with tiny retraction of pars flaccida.
    Lee JH; Hong SM; Kim CW; Park YH; Baek SH
    Auris Nasus Larynx; 2015 Apr; 42(2):107-12. PubMed ID: 25199742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction for mastoid extension of middle ear cholesteatoma using temporal subtraction serial HRCT studies.
    Baba A; Kurokawa R; Kurokawa M; Ota Y; Matsushima S; Fukuda T; Yamauchi H; Kano R; Shoji T; Kurihara S; Nakazawa T; Yamamoto Y; Kojima H; Srinivasan A; Ojiri H
    Eur Radiol; 2022 Jun; 32(6):3631-3638. PubMed ID: 35015126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in clinical characteristics of fallopian canal dehiscence associated with pars flaccida and pars tensa cholesteatomas.
    Shinnabe A; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Kanazawa H; Yoshida N; Iino Y
    Eur Arch Otorhinolaryngol; 2014 Aug; 271(8):2171-5. PubMed ID: 24071859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in middle ear ventilation disorders between pars flaccida and pars tensa cholesteatoma in sonotubometry and patterns of tympanic and mastoid pneumatization.
    Shinnabe A; Hara M; Hasegawa M; Matsuzawa S; Kanazawa H; Kanazawa T; Yoshida N; Iino Y
    Otol Neurotol; 2012 Jul; 33(5):765-8. PubMed ID: 22569150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tiny retraction of the pars flaccida may conceal an attic cholesteatoma.
    Kim GW; Jung HK; Sung JM; Kim JS; Kim CW
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):735-741. PubMed ID: 31802227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attic cholesteatoma with closure of the entrance to pars flaccida retraction pocket.
    Matsuzawa S; Iino Y; Yamamoto D; Hasegawa M; Hara M; Shinnabe A; Kanazawa H; Yoshida N
    Auris Nasus Larynx; 2017 Dec; 44(6):766-770. PubMed ID: 28041650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-echoplanar diffusion weighed imaging and T1-weighted imaging for cholesteatoma mastoid extension.
    Baba A; Kurihara S; Fukuda T; Yamauchi H; Matsushima S; Ikeda K; Kurokawa R; Ota Y; Takahashi M; Sakurai Y; Motegi M; Komori M; Yamamoto K; Yamamoto Y; Kojima H; Ojiri H
    Auris Nasus Larynx; 2021 Oct; 48(5):846-851. PubMed ID: 33461853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative prediction by artificial intelligence for mastoid extension in pars flaccida cholesteatoma using temporal bone high-resolution computed tomography: A retrospective study.
    Takahashi M; Noda K; Yoshida K; Tsuchida K; Yui R; Nakazawa T; Kurihara S; Baba A; Motegi M; Yamamoto K; Yamamoto Y; Ojiri H; Kojima H
    PLoS One; 2022; 17(10):e0273915. PubMed ID: 36190937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of middle ear aeration on surgical outcome after intact canal wall tympanoplasty for cholesteatoma.
    Motegi M; Yamamoto Y; Ouchi K; Akutsu T; Tada T; Kurihara S; Takahashi M; Sampei S; Sano H; Morino T; Komori M; Yamamoto K; Sakurai Y; Kojima H
    Auris Nasus Larynx; 2020 Dec; 47(6):965-975. PubMed ID: 32646631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of temporal subtraction computed tomography and non-echoplanar diffusion-weighted imaging for the mastoid extension of middle ear cholesteatoma.
    Baba A; Kurihara S; Kurokawa R; Kurokawa M; Ota Y; Matsushima S; Fukuda T; Yamauchi H; Kano R; Shoji T; Nakazawa T; Yamamoto Y; Kojima H; Srinivasan A; Ojiri H
    Auris Nasus Larynx; 2022 Dec; 49(6):956-963. PubMed ID: 35341626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan.
    Matsuda K; Tono T; Kojima H; Yamamoto Y; Sakagami M; Mishiro Y; Hinohira Y; Okuno T
    Auris Nasus Larynx; 2018 Feb; 45(1):45-50. PubMed ID: 28274504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of high-resolution computed tomography and magnetic resonance imaging in the detection of residual cholesteatomas in primary bony obliterated mastoids.
    De Foer B; Vercruysse JP; Pouillon M; Somers T; Casselman JW; Offeciers E
    Am J Otolaryngol; 2007; 28(4):230-4. PubMed ID: 17606036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mastoid bone pneumatization on the conformation and depth of the sinus tympani, a high-resolution computed tomography study.
    Baklaci D; Kuzucu I; Guler I; Akbal S; Kum NY; Yildirim GK; Parlak IS; Kum RO; Ozcan M
    Surg Radiol Anat; 2019 Aug; 41(8):921-926. PubMed ID: 31037347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributing factors in the pathogenesis of acquired cholesteatoma: size analysis based on MDCT.
    Yamashita K; Yoshiura T; Hiwatashi A; Tuvshinjargal D; Kamano H; Shiratsuchi H; Honda H
    AJR Am J Roentgenol; 2011 May; 196(5):1172-5. PubMed ID: 21512088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.
    Fukuda A; Morita S; Nakamaru Y; Hoshino K; Fujiwara K; Homma A
    J Int Adv Otol; 2019 Apr; 15(1):2-7. PubMed ID: 31058592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle-ear or mastoid granulation pathology associated with retraction of the pars flaccida and low-pitched tinnitus.
    Lou Z
    J Laryngol Otol; 2021 Apr; 135(4):332-335. PubMed ID: 33759738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Resolution Computed Tomography in Middle Ear Cholesteatoma: How Much Do We Need It?
    Stefanescu EH; Balica NC; Motoi SB; Grigorita L; Georgescu M; Iovanescu G
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.